NXGN-M: Nextgen Biomed Ltd - Summary | Jitta

Nextgen Biomed Ltd

ISR:NXGN-M

Price
₪0.53
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (11)
Recent Business Performance (33)
Financial Strength (38)
Return to Shareholders (13)
Competitive Advantage (12)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 142.85% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.84
95.01%
Pharmaceuticals
0.43
100.00%
2.37
100.00%
1.14
100.00%
COMPANY DESCRIPTION
Nextgen Biomed Ltd engages in research and development activities. It provides EyePen, a smart and modular device that consists of insulin injection pens and assists users in self-managing the diabetes treatment by recording the times and doses of insulin taken via injection it includes a camera, a voice-based monitoring system, a bluetooth component, a real-time image processor, connectivity and tracking of insulin injections using a dedicated mobile/computer/cloud application, based on AI that allows it to collect and manage information. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Rehovot, Israel.